US2013158649A1PendingUtilityA1
Biological stent-graft
Est. expiryMay 21, 2022(expired)· nominal 20-yr term from priority
Inventors:Timothy A. Chuter
A61F 2002/072A61F 2/062A61F 2/07
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A biological stent-graft and a method of making the same wherein a stent is surgically implanted in the lumen of an artery of a mammal, harvesting the stent-graft precursor after the stent has been incorporated into artery wall, fixing the harvested stent-graft precursor, and washing the same to yield a biological stent-graft.
Claims
exact text as granted — not AI-modified1 - 40 . (canceled)
41 . A biological stent-graft comprising a stent made from a biologically acceptable material and a non-laminate wall of a fixed animal blood vessel subject to fixation, the stent fully incorporated and encapsulated into the wall of the fixed animal blood vessel, and the non-laminated wall of a fixed animal blood vessel an ingrowth of smooth muscle and collagen into the stent.
42 . The stent-graft according to claim 41 wherein the stent is a metal stent.
43 . The stent-graft according to claim 41 wherein the stent is a polymeric stent.
44 . The biological stent-graft of claim 41 wherein the fixed animal blood vessel is a fixed animal arterial vessel.
45 . The biological stent-graft of claim 44 wherein the fixed animal arterial vessel is a fixed canine arterial vessel.
46 . The biological stent-graft of claim 44 wherein the fixed animal arterial vessel is a fixed bovine arterial vessel.
47 . The biological stent-graft of claim 44 wherein the fixed animal arterial vessel is a fixed porcine arterial vessel.
48 . The biological stent-graft of claim 41 wherein the stent is a self-expanding stent.
49 . The biological stent-graft of claim 41 wherein the stent is an expandable stent.
50 . The biological stent-graft of claim 41 wherein the fixed animal blood vessel is a glutaraldehyde fixed animal blood vessel.
51 . The biological stent-graft of claim 41 wherein the fixed animal blood vessel is glycerol triglycidy ether fixed animal blood vessel.
52 . A biological stent-graft comprising a stent made from a biologically acceptable material and a non-laminate wall of a fixed animal blood vessel, the stent in grown in and encapsulated in the walls of the animal blood vessel, and the non-laminated wall of a fixed animal blood vessel an ingrowth of smooth muscle and collagen into the stent.
53 . The stent-graft according to claim 52 wherein the stent is a metal stent.
54 . The stent-graft according to claim 52 wherein the stent is a polymeric stent.
55 . The biological stent-graft of claim 52 wherein the fixed animal blood vessel is a fixed animal arterial vessel.
56 . The biological stent-graft of claim 55 wherein the fixed animal arterial vessel is a fixed canine arterial vessel.
57 . The biological stent-graft of claim 55 wherein the fixed animal arterial vessel is a fixed bovine arterial vessel.
58 . The biological stent-graft of claim 55 wherein the fixed animal arterial vessel is a fixed porcine arterial vessel.
59 . The biological stent-graft of claim 52 wherein the stent is an expandable stent.
60 . A biological stent-graft comprising a stent made from a biological acceptable material and a non-laminate wall of a fixed and denatured animal blood vessel, the stent fully integrated into the wall of the fixed animal blood vessel.Join the waitlist — get patent alerts
Track US2013158649A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.